Myriad Genetics Inc Live Stock Price Today, Share Analysis and Chart

Name: Myriad Genetics, Inc.: Is Infosys Ltd. worth buying?
Item: Myriad Genetics, Inc.
Rating: 1.570486125
Author: Trendlyne DVM scores

Momentum Trap

about

Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11...

6.04 -0.07 (-1.15%)

60.96% Fall from 52W High

1.2M

XNAS Volume

XNAS 15 Jan, 2026 4:30 PM (EST)

Low Financial Strength

27.8 / 100

Expensive Valuation

25.8 / 100

Technically Neutral

44.3 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 36%

9 analysts

Myriad Genetics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Myriad Genetics Inc Live Stock Price Today, Share Analysis and Chart

Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11...

60.96% Fall from 52W High

SWOT Analysis

Myriad Genetics Inc Live Price Chart